A molecular assay for identification of two common transmitted diseases sexually.

Abbott announced a substantial addition to the m2000 system’s menu of checks in June with the FDA clearance of a fresh molecular assay to simultaneously detect gonorrhea and chlamydia, including a fresh variant strain of chlamydia found out in Sweden.ARCHITECTPLUS Helps to Manage Individuals and Improve Laboratory Efficiencies: Abbott’s ARCHITECTPLUS enhanced ARCHITECT category of immunochemistry analyzers will also be showcased at this year’s AACC. Continue reading